-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Upgrades Cross Country Healthcare to Outperform, Raises Price Target to $15

Benzinga·03/19/2026 17:30:36
Listen to the news
Wedbush analyst Michael Piccolo upgrades Cross Country Healthcare (NASDAQ:CCRN) from Neutral to Outperform and raises the price target from $11 to $15.